Wed, Jul 30, 2014, 9:08 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Celldex Therapeutics, Inc. Message Board

  • weightbayou weightbayou Apr 4, 2013 4:34 PM Flag

    Celldex owns today's immunotherapy conference.

    2:00 pm - 4:30 pm Session V: Making the System Work - Economic and Intellectual Challenges and Solutions
    Co-Chairs
    Martin A. "Mac" Cheever, MD - Fred Hutchinson Cancer Research Center
    Thomas Davis, MD - Celldex Therapeutics, Inc.
    Panel Discussion
    Martin A. "Mac" Cheever, MD - Fred Hutchinson Cancer Research Center
    Daniel S. Chen, MD, PhD - Genentech
    Gwen Darien - The Pathways Project
    Thomas Davis, MD - Celldex Therapeutics, Inc.
    Eric Rubin, MD - Merck & Company, Inc.
    Jonathan Skipper, PhD - Ludwig Institute for Cancer Research
    4:30 pm - 5:00 pm Summary and Conclusion
    Thomas A. Davis, MD - Celldex Therapeutics, Inc.
    Samir N. Khleif, MD - Georgia Regents University
    Howard Streicher, MD - National Institutes of Health

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Anybody know how that presentation went and what was discussed? Great that we are in the discussion, If anyone attended it woudl be nice if they posted a blurb on it.

      Sentiment: Strong Buy

      • 2 Replies to mymandon
      • I wish I knew how many people attended. I am surprised Celldex did not mention this on their website or in a PR. I guess things are going so well for them they are not concerned with something so mundane as a PR.

        Sentiment: Strong Buy

      • Celldex's Thomas Davis is scheduled to participate on a disccussion panel - Session V: Making the System Work - Economic and Intellectual Challenges and Solutions, at 2:00 p.m. I do not think that this will bring out any new information on any of CLDX products...it seems to be a general discussion about the current challenges that oncology biotechs face in today's markets.

 
CLDX
13.70+0.05(+0.37%)Jul 30 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
El Pollo Loco Holdings, Inc.
NasdaqGSWed, Jul 30, 2014 4:00 PM EDT
Yelp, Inc.
NYSEWed, Jul 30, 2014 4:00 PM EDT